Worldwide: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

D. Mass. Patent Litigation Update: July 2025

This is part of a series of articles discussing recent orders of interest issued in patent cases by the United States District Court for the District of Massachusetts.

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Reintroduction Of The BIOSECURE Act: Potential Impact On The Biotechnology Industry

The BIOSECURE Act ("the Act"), which received bipartisan support in both the U.S. House of Representatives and U.S. Senate in 2024 but was not ultimately passed into law, has re-emerged in this session of Congress, but with some important changes.

United States Healthcare

RG

Ropes & Gray LLP

Different Mechanism Leads To Lack Of Reasonable Expectation Of Success

The Patent Trial and Appeal Board recently reversed an obviousness finding of (non-signatory) Examiner Audrey Buttice, supported by Supervisory Patent Examienr (SPE) Joanne Hama...

United States Healthcare

OM

Oblon, McClelland, Maier & Neustadt, L.L.P

Five Health Care Issues To Watch As Congress Returns From August Recess

Health care is a consistently active area for policymakers on Capitol Hill. This alert highlights five health policy issues to watch as Congress returns from August recess...

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Leaked Draft Of MAHA Commission Strategy Report Outlines Sweeping Federal Actions On Chemicals In Food And The Environment

United States Healthcare

BD

Beveridge & Diamond

Regulatory Update: FDA Takes Action On Concentrated Kratom-Derivative Products

United States Healthcare

PC

Perkins Coie LLP

FDA's Removal Of Semaglutide And The Evolving Tirzepatide Decisions: What Compounders Need To Know

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Health Headlines: August 2025

United States Healthcare

GP

Goodwin Procter LLP

West Virginia Sues Pharmacy Benefit Manager For Manipulating Opioid Crisis

United States Healthcare

DM

Duane Morris LLP

United States Healthcare

BC

Bergeson & Campbell

NSF Announces Nearly $32 Million Investment To Accelerate AI-Driven Approaches In Protein Design, Strengthening The U.S. Bioeconomy

United States Environment

BC

Bergeson & Campbell

Trump Administration Announces U.S.-EU Trade Agreement, Including New Tariff Levels For Pharmaceuticals And Carveout For Generics

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

FDA Approves Expanded Indication For Celltrion's AVTOZMA For The Treatment Of Cytokine Release Syndrome

United States Healthcare

GP

Goodwin Procter LLP

Produce Paper, Packaging Or Food Serviceware? State Regulations Put Brands And Agencies At The Center Of Extended Producer Responsibility Laws

United States Healthcare

LL

Loeb & Loeb LLP

Arbitration Essentials: How To Initiate And Navigate An International Arbitration, Part 2: Hearings

United States Litigation

J

JAMS

AMTL's AICP Files Second Case Against TSMC, Its Advanced Memory Amends Against SK Hynix

United States IP

RC

RPX Corporation

Artificial Intelligence 2025 - Trends And Developments

United States Technology

SJ

Steptoe LLP

Are Emotional Distress Damages In FEHA Settlements Taxable?

United States Litigation

J

JAMS

ABA Labor & Employment Law Podcast

United States Immigration

Gs

Green and Spiegel

Congress Joins FDA In Focusing On Food Dye Limitations

Food dye reform has been an area of focus for the Trump administration as part of its Make America Healthy Again (MAHA) initiative, giving momentum to an effort the Food and Drug Administration (FDA) had already started by banning Red No. 3 for use in food and ingested drugs.

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Despite SEC's Sophisticated Methods Of Detection, Insider Trading Continues In The Life Sciences Industry

Many publicly traded companies in the life sciences industry are involved in the development of new drugs, devices, diagnostics, and medicines.

United States Healthcare

BS

Ballard Spahr LLP

Virtual And Digital Health Digest – August 2025

Welcome to the latest installment of Arnold & Porter's Virtual and Digital Health Digest.

United States Healthcare

AP

Arnold & Porter

Pharmacy Benefit Manager Ordered To Pay $290 Million For Medicare Overbilling

On August 20, 2025, a federal judge in the Eastern District of Pennsylvania ruled that Caremark should pay nearly $290 million in damages and penalties for overbilling the government for Medicare Part D drugs.

United States Healthcare

DM

Duane Morris LLP

FDA Continues Dismantling "Recipe Approach" To Food Standards Of Identity

United States Healthcare

SH

Shook, Hardy & Bacon

OMUFA Reauthorization On Deck As Congress Returns From Recess

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Impact Of The One Big Beautiful Bill Act On The Life Sciences Industry

United States Healthcare

BS

Ballard Spahr LLP

Lupin Announces Licensing Deal With Sandoz For Ranibizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

Podcast - Too Dirty For Dirty Crime

United States Criminal

HK

Holland & Knight

Antitrust In Flux: What's Shaping The Life Sciences Industry

United States Anti-trust

BS

Ballard Spahr LLP

Next-Generation Antibodies: A New Era In Immuno-Oncology

United States Healthcare

AM

Alvarez & Marsal

Most Favored Nation Drug Pricing Developments

United States Healthcare

AC

Ankura Consulting Group LLC

Ninth Circuit Affirms Dismissal Of Putative Class Action Against Pharmaceutical Company For Failure To Adequately Allege Falsity And Scienter

United States Litigation

AO

A&O Shearman

Legal Updates On Arkansas Law Banning PBMs From Owning Affiliated Pharmacies

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Next-Generation Antibodies: A New Era In Immuno-Oncology

As the immune checkpoint inhibitor (ICI) market nears a patent cliff, the $50B immuno-oncology (IO) field is now seeking to surpass the limitations of earlier ICIs by enhancing survival outcomes...

United States Healthcare

AM

Alvarez & Marsal

Most Favored Nation Drug Pricing Developments

On July 31, 2025, the White House released a fact sheet discussing additional steps taken by the Trump administration surrounding efforts towards lowering drug prices for Americans. The fact sheet was a follow-up to Executive Order (EO) 14297 signed May 12, 2025

United States Healthcare

AC

Ankura Consulting Group LLC

Ninth Circuit Affirms Dismissal Of Putative Class Action Against Pharmaceutical Company For Failure To Adequately Allege Falsity And Scienter

On August 20, 2025, the United States Court of Appeals for the Ninth Circuit affirmed the dismissal of a putative class action asserting claims under the Securities Exchange Act of 1934...

United States Litigation

AO

A&O Shearman

Legal Updates On Arkansas Law Banning PBMs From Owning Affiliated Pharmacies

In the rapidly changing landscape of healthcare, pharmacy benefit managers (PBMs) are increasingly under scrutiny for their significant influence on prescription drug pricing and patient access.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Ninth Circuit Says Improper Drug Marketing Slogan Does Not Suffice To Plead Exchange Act Claim

United States Healthcare

DP

Davis Polk & Wardwell

FDA Issues Guidance On AI For Medical Devices

The Food and Drug Administration (FDA) issued final guidance Monday that explains how medical device manufacturers can use a Predetermined Change Control Plan (PCCP) to update AI-enabled device...

United States Healthcare

BS

Ballard Spahr LLP

Securing Value: Patent Strategies For AI-Accelerated Drug Repurposing

Drug development can be slow, costly, and risky, often taking more than a decade and billions of dollars to bring a single therapy to the market.

United States IP

FL

Foley & Lardner

The Demise Of FDA's Administrative Summary Judgment Standard: Lessons From Vanda v. FDA

On August 15, 2025, the D.C. Circuit held that the U.S. Food and Drug Administration (FDA) had improperly denied Vanda Pharmaceuticals a hearing regarding Vanda's application to add a jet lag treatment indication...

United States Healthcare

AP

Arnold & Porter

Leaning Into Advanced Technologies To Support State Implementation Of New Federal Medicaid Requirements

H.R. 1, enacted by Congress in July, introduces substantial reforms to the Medicaid program, including new eligibility and enrollment requirements and restrictions...

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

Executive Order Directs HHS To Invest In Strategic Reserve Of Active Pharmaceutical Ingredients

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

Trump's Cannabis Plays, Explained

United States Cannabis

HS

Harris Sliwoski

Congress Revisits The BIOSECURE Act: Risks For Biotechnology Collaborations With Chinese Entities

United States Government

AP

Arnold & Porter

FTC Settles With NextMed Over Deceptive Pricing, Hidden Material Terms, And Fake Reviews And Testimonials In Telehealth Membership Programs

United States Media & IT

GA

Global Advertising Lawyers Alliance (GALA)

How A Pharma Business Transformed Its Batch Release With AI-Powered Document Mining

European Union Healthcare

AM

Alvarez & Marsal

Claiming A Range, Watch Out For The Presumption Of Obviousness

United States IP

SM

Sheppard Mullin Richter & Hampton

New Florida Law Attempts To Provide Leeway For Certain Stem Cell Treatments

United States Healthcare

HK

Holland & Knight

Cultivated Meat Snapshot: Recent Federal And State Actions

United States Healthcare

PC

Perkins Coie LLP

MN Rewrote The MinnesotaCare Tax Rules — But Tax Committees Never Saw It Coming

United States Tax

JW

Jones Walker

Check's In The Mail: HRSA Tests A New Script For 340B

United States Healthcare

D

Dykema

Recent Federal Developments For August 2025

United States Energy

BC

Bergeson & Campbell

Class Action Decisions Published April 2025

United States Healthcare

SH

Shook, Hardy & Bacon

HHS Pilot Program To Evaluate 340B Drug Pricing Program Rebate Models

United States Healthcare

JD

Jones Day

Telehealth And "In-Person Visits": Tracking Federal And State Updates To Pandemic Era Telehealth Exceptions

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Navigating Contract Manufacturing Agreements: Tips And Pitfalls For Pharma And Biopharma Companies

United States Healthcare

LS

Lowenstein Sandler

See more

Highlighted Content

The Nexus Of Trade And Food Security Amid Global Conflicts

United States International

BG

Braumiller Law Group, PLLC

Any Comments On FDA's New Proposed Rule On Prior Notice Regulations?

United States International

BG

Braumiller Law Group, PLLC

World Trade And Invasion, One Year Later – Are We On The Brink Of A New World Order?

United States International

BG

Braumiller Law Group, PLLC

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

Latest Videos

See more

Live From Workplace Horizons 2025: What's Hot In ERISA — Forfeiture And Tobacco Surcharge Class Actions (Video)

JL

Jackson Lewis P.C.

Navigating FDA Compliance And Civil Litigation: Strategies For Food And Medical Product Companies (Video)

AP

Arnold & Porter

Concerns For Employers Surrounding Employee Drug And Alcohol Testing Policies (Video)

FS

Foster Swift Collins & Smith

Food And Consumer Product Litigation And Regulatory Update: Webinar Replay (Video)

ML

McGuireWoods LLP

The Human Resource: Marijuana vs. A Drug Policy (Video)

BT

Barnes & Thornburg LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More